{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:03:33Z","timestamp":1769191413254,"version":"3.49.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    Polycystin-1 (PC1), encoded by the\n                    <jats:italic>PKD1<\/jats:italic>\n                    gene, forms a complex with polycystin-2 (\n                    <jats:italic>PKD2<\/jats:italic>\n                    ; 173910) that regulates multiple signaling pathways to maintain normal renal tubular structure and function. Mutations in the\n                    <jats:italic>PKD1<\/jats:italic>\n                    gene are the primary cause of type 1 PKD (polycystic kidney disease), accounting for 78%\u201385% of all PKD cases. In this study, we report a case of a boy presenting with microscopic hematuria with multiple renal cysts and carrying an unreported intronic variant, c.12445-34_12445-10del, in the\n                    <jats:italic>PKD1<\/jats:italic>\n                    gene inherited from his father who also presented PKD. Sanger sequencing and reverse transcription polymerase chain reaction (RT-PCR) for minigene splicing assays showed two abnormal splicing alterations with the c.12445-34_12445-10del variant at the mRNA level: one causes a 16-bp deletion in exon 46, resulting in premature protein termination (p.Phe4149GlyfsTer45), and the other results in a 205-bp deletion, leading to delayed termination (p.Phe4149ProfsTer139). Based on the clinical characteristics and gene mutations with functional verification, the patient was finally diagnosed with PKD caused by PKD1 function defection, as confirmed by the combined clinical features and genetic analysis. Management strategies include dietary management, blood pressure monitoring, and regular follow-up of kidney function. This is the first study to report an intronic deletion in the\n                    <jats:italic>PKD1<\/jats:italic>\n                    gene that influences alternative splicing. Our findings expand the mutation spectrum leading to PKD1-related diseases and highlight the importance of genetic counseling for the family.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2025.1707053","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:10:27Z","timestamp":1769119827000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["An intronic micro-deletion impacts the transcription and translation of PKD1 gene"],"prefix":"10.3389","volume":"16","author":[{"given":"Wei","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Perinatology, Maternal and Child Healthcare of Dongchangfu County","place":["Liaocheng, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinli","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Perinatology, Maternal and Child Healthcare of Dongchangfu County","place":["Liaocheng, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejing","family":"Sun","sequence":"additional","affiliation":[{"name":"Laboratory Department, Dongchangfu District Maternal and Child Health Hospital","place":["Liaocheng, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Wei","sequence":"additional","affiliation":[{"name":"Laboratory Department, Dongchangfu District Maternal and Child Health Hospital","place":["Liaocheng, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1046\/j.1523-1755.2001.00985.x","article-title":"Pain management in polycystic kidney disease","volume":"60","author":"Bajwa","year":"2001","journal-title":"Kidney Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1152\/physrev.00018.2024","article-title":"Physiologic mechanisms underlying polycystic kidney disease","volume":"105","author":"Boletta","year":"2025","journal-title":"Physiol. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/med.21850","article-title":"Autosomic dominant polycystic kidney disease and metformin: old knowledge and new insights on retarding progression of chronic kidney disease","volume":"42","author":"Casarella","year":"2022","journal-title":"Med. Res. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1001\/jama.2022.22847","article-title":"Exome sequencing of a clinical population for autosomal dominant polycystic kidney disease","volume":"328","author":"Chang","year":"2022","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1083\/jcb.201006173","article-title":"The cell biology of polycystic kidney disease","volume":"191","author":"Chapin","year":"2010","journal-title":"J. Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jama.2025.0310","article-title":"Autosomal dominant polycystic kidney disease: a review","volume":"333","author":"Chebib","year":"2025","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrneph.2017.177","article-title":"Genetics of kidney diseases in 2017: unveiling the genetic architecture of kidney disease","volume":"14","author":"Devuyst","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e70086","DOI":"10.1111\/ene.70086","article-title":"Novel PKD1 mutation (c.G10086T) drives high intracranial aneurysm risk in autosomal dominant polycystic kidney disease","volume":"32","author":"Gao","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1093\/hmg\/ddi356","article-title":"A splice form of polycystin-2, lacking exon 7, does not interact with polycystin-1","volume":"14","author":"Hackmann","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10157-017-1477-7","article-title":"A potentially crucial role of the PKD1 C-terminal tail in renal prognosis","volume":"22","author":"Higashihara","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneph.2014.104","article-title":"Renal transplantation in autosomal dominant polycystic kidney disease","volume":"10","author":"Kanaan","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.3390\/cells12172166","article-title":"Polycystin-1 interacting Protein-1 (CU062) interacts with the ectodomain of Polycystin-1 (PC1)","volume":"12","author":"Lea","year":"2023","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.ajhg.2022.06.013","article-title":"Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney diseaseand interstitial fibrosis","volume":"109","author":"Lemoine","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.1038\/s41467-022-35537-2","article-title":"Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev-pathol-042320-121247","article-title":"Polycystic liver disease: advances in understanding and treatment","volume":"17","author":"Masyuk","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41581-019-0183-y","article-title":"The pathobiology of polycystic kidney disease from a metabolic viewpoint","volume":"15","author":"Menezes","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1038\/s41467-023-37449-1","article-title":"The C-terminal tail of polycystin-1 suppresses cystic disease in a mitochondrial enzyme-dependent fashion","volume":"14","author":"Onuchic","year":"2023","journal-title":"Nat. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41581-018-0051-1","article-title":"Metabolism and mitochondria in polycystic kidney disease research and therapy","volume":"14","author":"Padovano","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrneph.2015.128","article-title":"Vascular complications in autosomal dominant polycystic kidney disease","volume":"11","author":"Perrone","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1681\/ASN.2011101032","article-title":"Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing","volume":"23","author":"Rossetti","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"eaat9819","DOI":"10.1126\/science.aat9819","article-title":"Structure of the human PKD1-PKD2 complex","volume":"361","author":"Su","year":"2018","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.kint.2024.07.010","article-title":"KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary","volume":"107","author":"Torres","year":"2025","journal-title":"Kidney Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2019.04.018","article-title":"Lanreotide reduces liver growth in patients with autosomal dominant polycystic liver and kidney disease","volume":"157","author":"van Aerts","year":"2019","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.addr.2020.08.011","article-title":"Targeting and therapeutic peptide-based strategies for polycystic kidney disease","author":"Wang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e27853","DOI":"10.1097\/MD.0000000000027853","article-title":"A de novo PKD1 mutation in a Chinese family with autosomal dominant polycystic kidney disease","volume":"103","author":"Wei","year":"2024","journal-title":"Med. Baltim."},{"key":"B28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1053\/j.ajkd.2024.10.009","article-title":"Clinical spectrum and prognosis of atypical autosomal dominant polycystic kidney disease caused by monoallelic pathogenic variants of IFT140","volume":"85","author":"Zagorec","year":"2025","journal-title":"Am. J. Kidney Dis."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1707053\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:10:28Z","timestamp":1769119828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1707053\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":28,"alternative-id":["10.3389\/fgene.2025.1707053"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1707053","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"article-number":"1707053"}}